Re-evolution of asthma management: dilemmas and new paradigms.
Asthma is one of the most common inflammatory diseases in the world, and the main treatment goal is to achieve the best level of control for each patient. Although every patient is different, there are several clinical practice guidelines that can help physicians to manage this respiratory condition. However, the recommendations made by the different guidelines are not always identical, and new data on different management strategies are being continuously released, which can mislead both patients and physicians. Our aim with this article is to summarize the main controversies in terms of management and treatment recommendations in asthma guidelines, revise the most recent scientific evidence published so far and pinpoint some possible solution to these dilemmas. This review, however, does not aim to issue new recommendations or to challenge evidence-based guidelines. As a conclusion of this article, the authors considered that more tools are necessary to reach and measure optimal asthma control, to better assess the impact of asthma in patients' lives. In addition, it would be of utmost importance to appraise more accurately the short-term and long-term effectiveness and safety of asthma therapies, and the possibilities of successful immunomodulation.